EU, UK evaluating FDA findings on Ranbaxy's Toansa facility

Last Updated: Wednesday, January 29, 2014, 17:09

The Medicines and Healthcare Products Regulatory Agency (MHRA) of UK said they are aware of the results of the FDAs inspection relating to GMP issues at the Toansa plant.

Ranbaxy stock nosedives 20% on USFDA restrictions

Last Updated: Friday, January 24, 2014, 14:05

Shares of Ranbaxy Laboratories Friday slumped as much as 20 percent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.

USFDA ban on Toansa plant disappointing: Ranbaxy

Last Updated: Friday, January 24, 2014, 13:51

Terming the USFDA ban on its Toansa plant 'disappointing', Ranbaxy Laboaratories Friday said it will take 'appropriate management action' for the lapses at the manufacturing facility after the conclusion of an internal investigation.

Ranbaxy hit by FDA product ban at 4th Indian plant; stock slumps 20%

Last Updated: Friday, January 24, 2014, 13:27

Ranbaxy shares fell as much as 19.43 percent on Friday to their lowest level in nearly four months.

Sensex falls over 200 points, Ranbaxy slumps nearly 20%

Last Updated: Friday, January 24, 2014, 11:21

Sensex slipped by over 200 points in the late morning trade to fall further from its record closing high pulled down by shares of Ranbaxy which fell about 20 percent following the banned of products by US FDA.

Ranbaxy falls around 16% after FDA bans products

Last Updated: Friday, January 24, 2014, 09:35

Shares in Ranbaxy Laboratories Ltd, majority owned by Japan`s Daiichi Sankyo Co Ltd, slumped around 16 percent in early trade after the US Food and Drug Administration banned more products from the Indian drugmaker.

Ranbaxy Laboratories hit again as US FDA bans more products

Last Updated: Friday, January 24, 2014, 06:07

In a setback to Indian pharmaceutical giant Ranbaxy, the US has prohibited the company from producing and distributing drugs for the American market from its Toansa facility in Punjab.

Ranbaxy shares falls on USFDA concerns

Last Updated: Tuesday, January 14, 2014, 11:57

Ranbaxy Laboratories shares fall 1.3 percent, adding to Monday`s 5.4 percent slump after the U.S. Food and Drug Administration raised concerns about manufacturing practices at one of its factories.

Ranbaxy slips over 5% on FDA concerns about Toansa plant

Last Updated: Monday, January 13, 2014, 18:51

After plunging 9.37 percent to Rs 420 in intra-day trade, the pharma major's scrip finally ended at Rs 438.35, down 5.42 percent at the BSE.

Ranbaxy's Toansa plant under USFDA's scanner

Last Updated: Monday, January 13, 2014, 18:39

Drug major Ranbaxy Laboratories Monday said the US health regulator has raised concerns over manufacturing practices at its Toansa plant in Punjab.

FDA raises more concerns about Ranbaxy's India plants

Last Updated: Monday, January 13, 2014, 15:41

The company, India`s biggest drugmaker by sales, said the FDA had now filed "certain observations" about its Toansa pharmaceutical ingredients plant in Punjab.

Ranbaxy gets Health Canada nod for generic anti-dementia drug

Last Updated: Wednesday, January 8, 2014, 19:13

Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept, a drug used for treatment of dementia in Alzheimer's patients.